{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:28:26Z","timestamp":1788449306484,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinthera.2025.05.004","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:19:59Z","timestamp":1748503199000},"page":"681-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Calcineurin Inhibitors and Risk of CNS Infections: A Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS)"],"prefix":"10.1016","volume":"47","author":[{"given":"Siming","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2025.05.004_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejps.2017.12.017","article-title":"Tacrolimus: an updated review on delivering strategies for multifarious diseases","volume":"114","author":"Dheer","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11012","article-title":"Solid organ donation and transplantation in the United Kingdom: good governance is key to success","volume":"36","author":"Johnston-Webber","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0003","doi-asserted-by":"crossref","first-page":"F336","DOI":"10.1152\/ajprenal.00262.2020","article-title":"Calcineurin inhibitors: a double-edged sword","volume":"320","author":"Ume","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0004","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1091581819870717","article-title":"Pharmacovigilance assessment of drug-induced acute pancreatitis using a spontaneous reporting database","volume":"38","author":"Niinomi","year":"2019","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.clinthera.2024.04.005","article-title":"Tacrolimus related acute pancreatitis: an observational, retrospective, pharmacovigilance study","volume":"46","author":"Yang","year":"2024","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0006","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/10738584211046888","article-title":"Calcineurin regulates synaptic plasticity and nociceptive transmission at the spinal cord level","volume":"28","author":"Huang","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0007","first-page":"92","article-title":"Topical tacrolimus in anterior segment disorders in ophthalmology: A review","volume":"68","author":"Alrashidi","year":"2024","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0008","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jtct.2024.03.017","article-title":"Neurologic complications of the Central nervous system after allogeneic stem cell transplantation: the role of transplantation-associated thrombotic microangiopathy as a potential underreported cause","volume":"30","author":"Sala","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jim-2021-001783","article-title":"Nocardiosis in renal transplant patients","volume":"70","author":"Gibson","year":"2022","journal-title":"J Investig Med"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40620-020-00956-1","article-title":"Immunosuppression-related neurological disorders in kidney transplantation","volume":"34","author":"Faravelli","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0011","doi-asserted-by":"crossref","DOI":"10.4103\/aian.aian_614_24","article-title":"Neurotoxicity of calcineurin inhibitors","author":"Bajon","year":"2025","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0012","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3324\/haematol.2022.281455","article-title":"Hemophagocytic lymphohistiocytosis and disseminated intravascular coagulation are underestimated, but fatal adverse events in chimeric antigen receptor T-cell therapy","volume":"108","author":"Song","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-024-01669-4","article-title":"Post-marketing safety concerns with lecanemab: a pharmacovigilance study based on the FDA Adverse Event Reporting System database","volume":"17","author":"Xing","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0014","article-title":"Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"Van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0017","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0018","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14740338.2022.2016696","article-title":"A real-world pharmacovigilance study of axitinib: data mining of the public version of FDA adverse event reporting system","volume":"21","author":"Shu","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.996179","article-title":"Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system","volume":"10","author":"Shu","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1425617","article-title":"Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS)","volume":"15","author":"Mao","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0021","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The REporting of A disproportionality analysis for DrUg safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.634449","article-title":"A review of infections after hematopoietic cell transplantation requiring PICU care: transplant timeline is key","volume":"9","author":"Ferdjallah","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0023","article-title":"Identifying CNS infections in transplantation and immunomodulatory therapy","volume":"11","author":"Alviz","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5114\/fn.2017.68577","article-title":"Neurologic complications in kidney transplant recipients","volume":"55","author":"Piotrowski","year":"2017","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2022.05.019","article-title":"Central nervous system infections in solid organ transplant recipients: results from the Swiss Transplant Cohort Study","volume":"85","author":"Van Den Bogaart","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/lt.24984","article-title":"Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation","volume":"24","author":"Pflugrad","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0027","doi-asserted-by":"crossref","first-page":"e8626","DOI":"10.1002\/ccr3.8626","article-title":"Progressive multifocal leukoencephalopathy in a lung transplant recipient","volume":"12","author":"Sakizadeh","year":"2024","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0028","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14740338.2024.2327503","article-title":"Data mining and safety analysis of traditional immunosuppressive drugs: a pharmacovigilance investigation based on the FAERS database","volume":"23","author":"Li","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1399-3062.2000.020302.x","article-title":"Infections of the central nervous system in transplant recipients","volume":"2","author":"Singh","year":"2000","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0030","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbmt.2016.12.632","article-title":"Neurologic complications after allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Maffini","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5812\/jnp.6","article-title":"Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: A review on tacrolimus and cyclosporin in organ transplantation","volume":"1","author":"Tolou-Ghamari","year":"2012","journal-title":"J Nephropathol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748019","article-title":"Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the Central nervous system","volume":"12","author":"Vinnakota","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0033","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5125\/jkaoms.2023.49.6.311","article-title":"Review of two immunosuppressants: tacrolimus and cyclosporine","volume":"49","author":"Lee","year":"2023","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0034","article-title":"Recent topics on the mechanisms of immunosuppressive therapy-related neurotoxicities","volume":"20","author":"Zhang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0035","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ncl.2011.07.002","article-title":"Central nervous system complications after transplantation","volume":"29","author":"Dhar","year":"2011","journal-title":"Neurol Clin"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0036","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3389\/fimmu.2018.01931","article-title":"Sex hormones determine immune response","volume":"9","author":"Taneja","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","article-title":"Considering how biological sex impacts immune responses and COVID-19 outcomes","volume":"20","author":"Scully","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0038","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0039","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2174\/1381612053381693","article-title":"Estrogen and cytokines production - the possible cause of gender differences in neurological diseases","volume":"11","author":"Czlonkowska","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121768","article-title":"The similarities and differences between the effects of testosterone and DHEA on the innate and adaptive immune response","volume":"12","author":"Buend\u00eda-Gonz\u00e1lez","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0041","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jceh.2022.03.012","article-title":"Long-term care of the adult liver transplant recipient","volume":"12","author":"Neuberger","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0042","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0733-8619(18)30868-5","article-title":"Infection of the central nervous system in organ transplant recipients","volume":"6","author":"Conti","year":"1988","journal-title":"Neurol Clin"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0733-8619(03)00070-7","article-title":"Central nervous system infection during immunosuppression","volume":"20","author":"Zunt","year":"2002","journal-title":"Neurol Clin"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0044","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/ciu428","article-title":"Central nervous system syndromes in solid organ transplant recipients","volume":"59","author":"Wright","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2024.2443783","article-title":"Skin cancer associated with calcineurin inhibitors treatment: analysis of FAERS database","author":"Zhu","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0046","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1200\/JCO.2012.42.1982","article-title":"Nocardia brain abscess in a patient treated with everolimus for a metastatic insulinoma","volume":"31","author":"Walter","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2025.05.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00569","article-title":"Listeria brain abscess in a patient with autoimmune hepatitis","volume":"17","author":"Trachuk","year":"2019","journal-title":"IDCases"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825001687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291825001687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T05:03:27Z","timestamp":1763787807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291825001687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0149291825001687"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.05.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcineurin Inhibitors and Risk of CNS Infections: A Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS)","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2025.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}